Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of CT1812 in Healthy Adult Male Subjects

Clinical trial NCT05225389 · COMPLETED

Trial details

NCT number: NCT05225389
Sponsor: Cognition Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2021-12-31
Primary completion: 2022-01-17
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.